,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-3371497,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),8/107,46/8183,1.13467707870222e-07,4.8110308136974e-05,4.10872542182698e-05,HSPA1B/HSPA1A/HSPA2/TUBB2A/DNAJB1/TUBA1B/TUBA1A/DYNLL1,8
R-HSA-2262752,R-HSA-2262752,Cellular responses to stress,18/107,378/8183,1.61847981756922e-06,0.000323426386439146,0.000276213199938099,HSPA1B/FOS/HSPA1A/HSPA6/HSPA2/TUBB2A/ID1/DNAJB1/JUN/TUBA1B/CITED2/HSPH1/TUBA1A/CYCS/DYNLL1/CYBA/VEGFA/HSPA5,18
R-HSA-8953897,R-HSA-8953897,Cellular responses to external stimuli,20/107,470/8183,2.2883942436732e-06,0.000323426386439146,0.000276213199938099,HSPA1B/FOS/HSPA1A/HSPA6/HSPA2/TUBB2A/ID1/DNAJB1/JUN/MAP1LC3B/TUBA1B/CITED2/HSPH1/TUBA1A/CYCS/DYNLL1/CYBA/VEGFA/HSPA5/TOMM20,20
R-HSA-3371453,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,7/107,67/8183,2.4488325803751e-05,0.00212080124546722,0.00181121059692335,HSPA1B/HSPA1A/HSPA6/HSPA2/DNAJB1/HSPH1/HSPA5,7
R-HSA-3371568,R-HSA-3371568,Attenuation phase,4/107,14/8183,2.50094486493776e-05,0.00212080124546722,0.00181121059692335,HSPA1B/HSPA1A/HSPA2/DNAJB1,4
R-HSA-389977,R-HSA-389977,Post-chaperonin tubulin folding pathway,4/107,16/8183,4.4563244560489e-05,0.00314913594894122,0.00268943089979091,TUBB2A/TUBA1B/TUBA1A/TBCC,4
R-HSA-3371556,R-HSA-3371556,Cellular response to heat stress,7/107,87/8183,0.00013283936101679,0.0080462698673027,0.00687169025410161,HSPA1B/HSPA1A/HSPA6/HSPA2/DNAJB1/HSPH1/HSPA5,7
R-HSA-3371571,R-HSA-3371571,HSF1-dependent transactivation,4/107,24/8183,0.000240035976012591,0.0127219067286673,0.0108647862826752,HSPA1B/HSPA1A/HSPA2/DNAJB1,4
R-HSA-70263,R-HSA-70263,Gluconeogenesis,4/107,27/8183,0.000384666190447058,0.0169172319785031,0.0144476857016015,ALDOA/GPI/ENO1/PGK1,4
R-HSA-190840,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,3/107,12/8183,0.000438890452272486,0.0169172319785031,0.0144476857016015,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-190872,R-HSA-190872,Transport of connexons to the plasma membrane,3/107,12/8183,0.000438890452272486,0.0169172319785031,0.0144476857016015,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-190861,R-HSA-190861,Gap junction assembly,3/107,19/8183,0.00180852390826444,0.0589857028541633,0.0503750789022646,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-389960,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,3/107,19/8183,0.00180852390826444,0.0589857028541633,0.0503750789022646,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-114608,R-HSA-114608,Platelet degranulation ,6/107,103/8183,0.00222580339109787,0.0630773733221457,0.0538694548729347,CFL1/TAGLN2/ALDOA/VEGFA/HSPA5/TMSB4X,6
R-HSA-6811436,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,4/107,43/8183,0.00230424941480384,0.0630773733221457,0.0538694548729347,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-6785807,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,5/107,72/8183,0.00243059553849644,0.0630773733221457,0.0538694548729347,FOS/JUNB/SOCS1/MCL1/VEGFA,5
R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,6/107,106/8183,0.00257326411343244,0.0630773733221457,0.0538694548729347,CFL1/TAGLN2/ALDOA/VEGFA/HSPA5/TMSB4X,6
R-HSA-9619483,R-HSA-9619483,Activation of AMPK downstream of NMDARs,3/107,22/8183,0.0027935530148951,0.0630773733221457,0.0538694548729347,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-72706,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,6/107,108/8183,0.0028265804083037,0.0630773733221457,0.0538694548729347,RPL24/RPL14/EIF5/RPL35A/EIF4A2/RPL11,6
R-HSA-109606,R-HSA-109606,Intrinsic Pathway for Apoptosis,4/107,48/8183,0.00345623043300536,0.0732720851797137,0.0625759615238866,SFN/PMAIP1/CYCS/DYNLL1,4
R-HSA-72613,R-HSA-72613,Eukaryotic Translation Initiation,6/107,115/8183,0.00386231469652552,0.0739227441831118,0.0631316385277817,RPL24/RPL14/EIF5/RPL35A/EIF4A2/RPL11,6
R-HSA-72737,R-HSA-72737,Cap-dependent Translation Initiation,6/107,115/8183,0.00386231469652552,0.0739227441831118,0.0631316385277817,RPL24/RPL14/EIF5/RPL35A/EIF4A2/RPL11,6
R-HSA-5620924,R-HSA-5620924,Intraflagellar transport,4/107,50/8183,0.00400996017974427,0.0739227441831118,0.0631316385277817,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-389958,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,3/107,26/8183,0.00454106261542571,0.0770164219576201,0.0657737069350082,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-5626467,R-HSA-5626467,RHO GTPases activate IQGAPs,3/107,26/8183,0.00454106261542571,0.0770164219576201,0.0657737069350082,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-3700989,R-HSA-3700989,Transcriptional Regulation by TP53,11/107,344/8183,0.00516802973311587,0.0842786387246588,0.071975798712221,FOS/BTG2/SGK1/JUN/SFN/PMAIP1/PCNA/GPI/NDUFA4/NDRG1/CYCS,11
R-HSA-114452,R-HSA-114452,Activation of BH3-only proteins,3/107,29/8183,0.00620353347762191,0.0939392212325603,0.0802261472293961,SFN/PMAIP1/DYNLL1,3
R-HSA-190828,R-HSA-190828,Gap junction trafficking,3/107,29/8183,0.00620353347762191,0.0939392212325603,0.0802261472293961,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-381042,R-HSA-381042,PERK regulates gene expression,3/107,30/8183,0.00682805474422227,0.0962177960915555,0.0821720999391636,ATF3/HERPUD1/HSPA5,3
R-HSA-1234158,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,2/107,10/8183,0.00711833319784411,0.0962177960915555,0.0821720999391636,CITED2/VEGFA,2
R-HSA-450341,R-HSA-450341,Activation of the AP-1 family of transcription factors,2/107,10/8183,0.00711833319784411,0.0962177960915555,0.0821720999391636,FOS/JUN,2
R-HSA-157858,R-HSA-157858,Gap junction trafficking and regulation,3/107,31/8183,0.00748864922410691,0.0962177960915555,0.0821720999391636,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-9609736,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,3/107,31/8183,0.00748864922410691,0.0962177960915555,0.0821720999391636,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-8955332,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,3/107,32/8183,0.00818579312616379,0.10208165545569,0.0871799639442832,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-70171,R-HSA-70171,Glycolysis,4/107,62/8183,0.00862085146008545,0.104435457687892,0.0891901624742675,ALDOA/GPI/ENO1/PGK1,4
R-HSA-8864260,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,3/107,33/8183,0.00891992531180667,0.105056898116834,0.0897208861772367,CITED4/CITED2/VEGFA,3
R-HSA-168255,R-HSA-168255,Influenza Life Cycle,6/107,139/8183,0.00959246973685161,0.107408492387315,0.0917291990596732,HSPA1B/HSPA1A/RPL24/RPL14/RPL35A/RPL11,6
R-HSA-1445148,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,4/107,64/8183,0.0096262328082971,0.107408492387315,0.0917291990596732,TUBB2A/SFN/TUBA1B/TUBA1A,4
R-HSA-381771,R-HSA-381771,Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1),2/107,12/8183,0.0102638245356306,0.111586194951472,0.0952970483200254,SEC11C/GRP,2
R-HSA-400508,R-HSA-400508,Incretin synthesis, secretion, and inactivation,2/107,13/8183,0.0120272209890828,0.127488542484278,0.108878000532749,SEC11C/GRP,2
R-HSA-156827,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,5/107,107/8183,0.01290287029382,0.132051453156243,0.112774825932839,RPL24/RPL14/RPL35A/EIF4A2/RPL11,5
R-HSA-168254,R-HSA-168254,Influenza Infection,6/107,149/8183,0.0132120502726044,0.132051453156243,0.112774825932839,HSPA1B/HSPA1A/RPL24/RPL14/RPL35A/RPL11,6
R-HSA-1799339,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,5/107,108/8183,0.0133920105795246,0.132051453156243,0.112774825932839,SEC11C/RPL24/RPL14/RPL35A/RPL11,5
R-HSA-437239,R-HSA-437239,Recycling pathway of L1,3/107,40/8183,0.0151240457209794,0.145740804220347,0.124465830813802,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-2408522,R-HSA-2408522,Selenoamino acid metabolism,5/107,113/8183,0.0160262701358174,0.151003078613035,0.128959928110437,RPL24/RPL14/RPL35A/DARS/RPL11,5
R-HSA-1428517,R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,6/107,158/8183,0.0172081414984513,0.158614173811812,0.135459969690326,LDHA/PDK4/NDUFA4/CYCS/NDUFB4/NDUFS5,6
R-HSA-76002,R-HSA-76002,Platelet activation, signaling and aggregation,7/107,207/8183,0.0185493011511456,0.166233373355884,0.141966932558153,RHOB/CFL1/TAGLN2/ALDOA/VEGFA/HSPA5/TMSB4X,7
R-HSA-70326,R-HSA-70326,Glucose metabolism,4/107,78/8183,0.0188188724553831,0.166233373355884,0.141966932558153,ALDOA/GPI/ENO1/PGK1,4
R-HSA-5628897,R-HSA-5628897,TP53 Regulates Metabolic Genes,4/107,81/8183,0.0213108747088646,0.180716217531172,0.154335597891567,SFN/GPI/NDUFA4/CYCS,4
R-HSA-5687128,R-HSA-5687128,MAPK6/MAPK4 signaling,4/107,81/8183,0.0213108747088646,0.180716217531172,0.154335597891567,HSPB1/DNAJB1/JUN/CDC42EP3,4
R-HSA-6804114,R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,2/107,18/8183,0.0226123710097811,0.187968797285871,0.160529459449701,SFN/PCNA,2
R-HSA-6791312,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,3/107,48/8183,0.024566906852028,0.187968797285871,0.160529459449701,BTG2/SFN/PCNA,3
R-HSA-156902,R-HSA-156902,Peptide chain elongation,4/107,85/8183,0.0249353353833998,0.187968797285871,0.160529459449701,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-192823,R-HSA-192823,Viral mRNA Translation,4/107,85/8183,0.0249353353833998,0.187968797285871,0.160529459449701,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-110320,R-HSA-110320,Translesion Synthesis by POLH,2/107,19/8183,0.025059882433489,0.187968797285871,0.160529459449701,PCNA/UFD1,2
R-HSA-450531,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,4/107,86/8183,0.0258961106412391,0.187968797285871,0.160529459449701,HSPA1B/HSPA1A/HSPB1/ZFP36,4
R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,10/107,379/8183,0.026101660941198,0.187968797285871,0.160529459449701,HSPA1B/HSPA1A/HSPA6/FABP5/PGRMC1/ALDOA/GPI/APRT/DYNLL1/CYBA,10
R-HSA-983189,R-HSA-983189,Kinesins,3/107,50/8183,0.0273249907695736,0.187968797285871,0.160529459449701,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-5627117,R-HSA-5627117,RHO GTPases Activate ROCKs,2/107,20/8183,0.0276101396379474,0.187968797285871,0.160529459449701,RHOB/CFL1,2
R-HSA-380320,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,4/107,88/8183,0.0278839385091637,0.187968797285871,0.160529459449701,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-391251,R-HSA-391251,Protein folding,4/107,88/8183,0.0278839385091637,0.187968797285871,0.160529459449701,TUBB2A/TUBA1B/TUBA1A/TBCC,4
R-HSA-5663220,R-HSA-5663220,RHO GTPases Activate Formins,5/107,131/8183,0.0283054863842505,0.187968797285871,0.160529459449701,RHOB/TUBB2A/TUBA1B/TUBA1A/DYNLL1,5
R-HSA-156842,R-HSA-156842,Eukaryotic Translation Elongation,4/107,89/8183,0.0289111593512949,0.187968797285871,0.160529459449701,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-2408557,R-HSA-2408557,Selenocysteine synthesis,4/107,89/8183,0.0289111593512949,0.187968797285871,0.160529459449701,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-72764,R-HSA-72764,Eukaryotic Translation Termination,4/107,89/8183,0.0289111593512949,0.187968797285871,0.160529459449701,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-611105,R-HSA-611105,Respiratory electron transport,4/107,90/8183,0.0299606856091931,0.187968797285871,0.160529459449701,NDUFA4/CYCS/NDUFB4/NDUFS5,4
R-HSA-112409,R-HSA-112409,RAF-independent MAPK1/3 activation,2/107,21/8183,0.030260090643257,0.187968797285871,0.160529459449701,DUSP2/DUSP1,2
R-HSA-5205685,R-HSA-5205685,Pink/Parkin Mediated Mitophagy,2/107,21/8183,0.030260090643257,0.187968797285871,0.160529459449701,MAP1LC3B/TOMM20,2
R-HSA-6807878,R-HSA-6807878,COPI-mediated anterograde transport,4/107,91/8183,0.031032584457573,0.187968797285871,0.160529459449701,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-975956,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),4/107,91/8183,0.031032584457573,0.187968797285871,0.160529459449701,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-450408,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,3/107,54/8183,0.0333161817273899,0.198958606372018,0.169914996504405,HSPA1B/HSPA1A/HSPB1,3
R-HSA-72766,R-HSA-72766,Translation,8/107,287/8183,0.0339610565443185,0.199992888538765,0.170798296070842,SEC11C/RPL24/RPL14/EIF5/RPL35A/DARS/EIF4A2/RPL11,8
R-HSA-195258,R-HSA-195258,RHO GTPase Effectors,8/107,291/8183,0.0364146721325892,0.21150439704408,0.180629375827119,RHOB/TUBB2A/SFN/TUBA1B/CFL1/TUBA1A/DYNLL1/CYBA,8
R-HSA-72689,R-HSA-72689,Formation of a pool of free 40S subunits,4/107,97/8183,0.0379367290560169,0.216343179542926,0.184761801794356,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-191273,R-HSA-191273,Cholesterol biosynthesis,2/107,24/8183,0.0387784944463735,0.216343179542926,0.184761801794356,MSMO1/FDFT1,2
R-HSA-389957,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,2/107,24/8183,0.0387784944463735,0.216343179542926,0.184761801794356,TUBB2A/TUBA1A,2
R-HSA-2173788,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,2/107,25/8183,0.0417979039764706,0.227209119051584,0.194041551523696,PPP1R15A/BAMBI,2
R-HSA-380994,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,2/107,25/8183,0.0417979039764706,0.227209119051584,0.194041551523696,ATF3/HERPUD1,2
R-HSA-1222556,R-HSA-1222556,ROS and RNS production in phagocytes,2/107,26/8183,0.0449026407565577,0.240101214357071,0.205051682569097,ATP6V0B/CYBA,2
R-HSA-2980736,R-HSA-2980736,Peptide hormone metabolism,3/107,61/8183,0.0453021159164284,0.240101214357071,0.205051682569097,CPB1/SEC11C/GRP,3
R-HSA-2132295,R-HSA-2132295,MHC class II antigen presentation,4/107,107/8183,0.0512552678409165,0.259232307762379,0.221390054295577,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-3299685,R-HSA-3299685,Detoxification of Reactive Oxygen Species,2/107,28/8183,0.0513573439906599,0.259232307762379,0.221390054295577,CYCS/CYBA,2
R-HSA-5205647,R-HSA-5205647,Mitophagy,2/107,28/8183,0.0513573439906599,0.259232307762379,0.221390054295577,MAP1LC3B/TOMM20,2
R-HSA-70268,R-HSA-70268,Pyruvate metabolism,2/107,28/8183,0.0513573439906599,0.259232307762379,0.221390054295577,LDHA/PDK4,2
R-HSA-163200,R-HSA-163200,Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.,4/107,110/8183,0.0556915623910033,0.277802617103358,0.23724950417963,NDUFA4/CYCS/NDUFB4/NDUFS5,4
R-HSA-927802,R-HSA-927802,Nonsense-Mediated Decay (NMD),4/107,111/8183,0.0572151969433992,0.278841879356336,0.238137056848509,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-975957,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),4/107,111/8183,0.0572151969433992,0.278841879356336,0.238137056848509,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-2871796,R-HSA-2871796,FCERI mediated MAPK activation,2/107,30/8183,0.0581216432632657,0.280040644813916,0.239160828738796,FOS/JUN,2
R-HSA-438064,R-HSA-438064,Post NMDA receptor activation events,3/107,68/8183,0.059135375764731,0.280904895999378,0.239898918132537,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-8852276,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,3/107,69/8183,0.0612567544772414,0.280904895999378,0.239898918132537,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-2173789,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,2/107,31/8183,0.0616135738866559,0.280904895999378,0.239898918132537,PPP1R15A/BAMBI,2
R-HSA-450282,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/107,31/8183,0.0616135738866559,0.280904895999378,0.239898918132537,FOS/JUN,2
R-HSA-5362517,R-HSA-5362517,Signaling by Retinoic Acid,2/107,31/8183,0.0616135738866559,0.280904895999378,0.239898918132537,FABP5/PDK4,2
R-HSA-168274,R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,2/107,32/8183,0.0651754259373554,0.292806052983593,0.250062766202473,HSPA1B/HSPA1A,2
R-HSA-170834,R-HSA-170834,Signaling by TGF-beta Receptor Complex,3/107,71/8183,0.0656051297958522,0.292806052983593,0.250062766202473,PPP1R15A/JUNB/BAMBI,3
R-HSA-9006931,R-HSA-9006931,Signaling by Nuclear Receptors,6/107,221/8183,0.0692245674493009,0.305741839567745,0.26111021055438,FOS/FOSB/HSPB1/JUN/FABP5/PDK4,6
R-HSA-2500257,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,4/107,119/8183,0.0702025709882778,0.30686484638175,0.26206928290795,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-8856688,R-HSA-8856688,Golgi-to-ER retrograde transport,4/107,121/8183,0.0736681518469517,0.318727514113342,0.272200260315267,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-442755,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,3/107,76/8183,0.0770752535472508,0.330100075798327,0.281912676451401,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-109582,R-HSA-109582,Hemostasis,10/107,461/8183,0.0785008087476311,0.332843429089956,0.284255560096685,RHOB/TUBB2A/TUBA1B/CFL1/TAGLN2/ALDOA/TUBA1A/VEGFA/HSPA5/TMSB4X,10
R-HSA-383280,R-HSA-383280,Nuclear Receptor transcription pathway,2/107,36/8183,0.0800750575614466,0.336156677287657,0.287085146442289,NR4A1/NR4A2,2
R-HSA-5633008,R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,2/107,37/8183,0.0839516969385644,0.34897568139168,0.298032856004811,PMAIP1/NDRG1,2
R-HSA-6791226,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,5/107,179/8183,0.0850264910886933,0.350011963316563,0.298917863408385,RPL24/RPL14/RPL35A/BUD23/RPL11,5
R-HSA-168273,R-HSA-168273,Influenza Viral RNA Transcription and Replication,4/107,129/8183,0.0883805580227341,0.360320736554224,0.307721780969843,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-110313,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,2/107,39/8183,0.0918718554444746,0.364218937852697,0.311050930043018,PCNA/UFD1,2
R-HSA-5675221,R-HSA-5675221,Negative regulation of MAPK pathway,2/107,39/8183,0.0918718554444746,0.364218937852697,0.311050930043018,DUSP2/DUSP1,2
R-HSA-390466,R-HSA-390466,Chaperonin-mediated protein folding,3/107,82/8183,0.091913741392072,0.364218937852697,0.311050930043018,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-168898,R-HSA-168898,Toll-like Receptor Cascades,4/107,133/8183,0.0962326723521252,0.377802343308344,0.322651455059757,FOS/SOCS1/JUN/S100A1,4
R-HSA-8868773,R-HSA-8868773,rRNA processing in the nucleus and cytosol,5/107,189/8183,0.101333196539316,0.394176837914402,0.336635631188069,RPL24/RPL14/RPL35A/BUD23/RPL11,5
R-HSA-5683057,R-HSA-5683057,MAPK family signaling cascades,6/107,246/8183,0.102803716236478,0.396261597129698,0.338416061103814,DUSP2/DUSP1/HSPB1/DNAJB1/JUN/CDC42EP3,6
R-HSA-381119,R-HSA-381119,Unfolded Protein Response (UPR),3/107,87/8183,0.105113503735276,0.401514644898712,0.342902278662257,ATF3/HERPUD1/HSPA5,3
R-HSA-1632852,R-HSA-1632852,Macroautophagy,3/107,89/8183,0.11059255869195,0.407374054898688,0.347906342813179,MAP1LC3B/DYNLL1/TOMM20,3
R-HSA-166058,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,3/107,89/8183,0.11059255869195,0.407374054898688,0.347906342813179,FOS/SOCS1/JUN,3
R-HSA-168188,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,3/107,89/8183,0.11059255869195,0.407374054898688,0.347906342813179,FOS/SOCS1/JUN,3
R-HSA-6811434,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,3/107,89/8183,0.11059255869195,0.407374054898688,0.347906342813179,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-199977,R-HSA-199977,ER to Golgi Anterograde Transport,4/107,141/8183,0.112882013697644,0.407374054898688,0.347906342813179,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-168179,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,3/107,90/8183,0.113372968108597,0.407374054898688,0.347906342813179,FOS/SOCS1/JUN,3
R-HSA-181438,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,3/107,90/8183,0.113372968108597,0.407374054898688,0.347906342813179,FOS/SOCS1/JUN,3
R-HSA-4420097,R-HSA-4420097,VEGFA-VEGFR2 Pathway,3/107,91/8183,0.116180026642155,0.413952363834232,0.353524362360913,HSPB1/CYBA/VEGFA,3
R-HSA-72312,R-HSA-72312,rRNA processing,5/107,198/8183,0.11725615287657,0.414305073497215,0.353825584118774,RPL24/RPL14/RPL35A/BUD23/RPL11,5
R-HSA-9006936,R-HSA-9006936,Signaling by TGF-beta family members,3/107,92/8183,0.119013277549572,0.415220517846131,0.354607393592525,PPP1R15A/JUNB/BAMBI,3
R-HSA-111458,R-HSA-111458,Formation of apoptosome,1/107,10/8183,0.123391002944841,0.415220517846131,0.354607393592525,CYCS,1
R-HSA-174437,R-HSA-174437,Removal of the Flap Intermediate from the C-strand,1/107,10/8183,0.123391002944841,0.415220517846131,0.354607393592525,PCNA,1
R-HSA-2022377,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,1/107,10/8183,0.123391002944841,0.415220517846131,0.354607393592525,CPB1,1
R-HSA-381183,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,1/107,10/8183,0.123391002944841,0.415220517846131,0.354607393592525,HSPA5,1
R-HSA-9627069,R-HSA-9627069,Regulation of the apoptosome activity,1/107,10/8183,0.123391002944841,0.415220517846131,0.354607393592525,CYCS,1
R-HSA-71291,R-HSA-71291,Metabolism of amino acids and derivatives,7/107,320/8183,0.125215214353628,0.417400052170452,0.356468763521936,SAT1/RPL24/RPL14/GLUL/RPL35A/DARS/RPL11,7
R-HSA-1650814,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,2/107,48/8183,0.129871156740954,0.417400052170452,0.356468763521936,P4HA1/PPIB,2
R-HSA-73893,R-HSA-73893,DNA Damage Bypass,2/107,48/8183,0.129871156740954,0.417400052170452,0.356468763521936,PCNA/UFD1,2
R-HSA-194138,R-HSA-194138,Signaling by VEGF,3/107,97/8183,0.133556319030327,0.417400052170452,0.356468763521936,HSPB1/CYBA/VEGFA,3
R-HSA-6799198,R-HSA-6799198,Complex I biogenesis,2/107,49/8183,0.13429435111571,0.417400052170452,0.356468763521936,NDUFB4/NDUFS5,2
R-HSA-174403,R-HSA-174403,Glutathione synthesis and recycling,1/107,11/8183,0.134867469687151,0.417400052170452,0.356468763521936,GGCT,1
R-HSA-174414,R-HSA-174414,Processive synthesis on the C-strand of the telomere,1/107,11/8183,0.134867469687151,0.417400052170452,0.356468763521936,PCNA,1
R-HSA-5686938,R-HSA-5686938,Regulation of TLR by endogenous ligand,1/107,11/8183,0.134867469687151,0.417400052170452,0.356468763521936,S100A1,1
R-HSA-8866910,R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,1/107,11/8183,0.134867469687151,0.417400052170452,0.356468763521936,VEGFA,1
R-HSA-8934903,R-HSA-8934903,Receptor Mediated Mitophagy,1/107,11/8183,0.134867469687151,0.417400052170452,0.356468763521936,MAP1LC3B,1
R-HSA-9614399,R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/107,11/8183,0.134867469687151,0.417400052170452,0.356468763521936,SFN,1
R-HSA-373760,R-HSA-373760,L1CAM interactions,3/107,100/8183,0.142566914469637,0.420282627959026,0.358930546221214,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-111461,R-HSA-111461,Cytochrome c-mediated apoptotic response,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,CYCS,1
R-HSA-381033,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,HSPA5,1
R-HSA-422085,R-HSA-422085,Synthesis, secretion, and deacylation of Ghrelin,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,SEC11C,1
R-HSA-5083625,R-HSA-5083625,Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,MUC12,1
R-HSA-5083636,R-HSA-5083636,Defective GALNT12 causes colorectal cancer 1 (CRCS1),1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,MUC12,1
R-HSA-6803205,R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,NDRG1,1
R-HSA-74217,R-HSA-74217,Purine salvage,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,APRT,1
R-HSA-8866427,R-HSA-8866427,VLDLR internalisation and degradation,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,MYLIP,1
R-HSA-912694,R-HSA-912694,Regulation of IFNA signaling,1/107,12/8183,0.146195073791835,0.420282627959026,0.358930546221214,SOCS1,1
R-HSA-71406,R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,2/107,52/8183,0.147760669779608,0.420282627959026,0.358930546221214,LDHA/PDK4,2
R-HSA-909733,R-HSA-909733,Interferon alpha/beta signaling,2/107,52/8183,0.147760669779608,0.420282627959026,0.358930546221214,EGR1/SOCS1,2
R-HSA-5610787,R-HSA-5610787,Hedgehog 'off' state,3/107,102/8183,0.148684891966636,0.420282627959026,0.358930546221214,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-5083632,R-HSA-5083632,Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),1/107,13/8183,0.157375728192064,0.432766062444974,0.369591671998687,MUC12,1
R-HSA-75035,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,1/107,13/8183,0.157375728192064,0.432766062444974,0.369591671998687,SFN,1
R-HSA-877312,R-HSA-877312,Regulation of IFNG signaling,1/107,13/8183,0.157375728192064,0.432766062444974,0.369591671998687,SOCS1,1
R-HSA-194315,R-HSA-194315,Signaling by Rho GTPases,8/107,405/8183,0.159585515346012,0.432766062444974,0.369591671998687,RHOB/TUBB2A/SFN/TUBA1B/CFL1/TUBA1A/DYNLL1/CYBA,8
R-HSA-449147,R-HSA-449147,Signaling by Interleukins,7/107,342/8183,0.159862858810712,0.432766062444974,0.369591671998687,FOS/JUNB/SOCS1/MCL1/JUN/CFL1/VEGFA,7
R-HSA-9010553,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,4/107,162/8183,0.161994956767426,0.432766062444974,0.369591671998687,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-109581,R-HSA-109581,Apoptosis,4/107,163/8183,0.164507720780554,0.432766062444974,0.369591671998687,SFN/PMAIP1/CYCS/DYNLL1,4
R-HSA-9614085,R-HSA-9614085,FOXO-mediated transcription,2/107,56/8183,0.166116689537934,0.432766062444974,0.369591671998687,SFN/CITED2,2
R-HSA-111471,R-HSA-111471,Apoptotic factor-mediated response,1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,CYCS,1
R-HSA-174411,R-HSA-174411,Polymerase switching on the C-strand of the telomere,1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,PCNA,1
R-HSA-5358565,R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,PCNA,1
R-HSA-5358606,R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,PCNA,1
R-HSA-69091,R-HSA-69091,Polymerase switching,1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,PCNA,1
R-HSA-69109,R-HSA-69109,Leading Strand Synthesis,1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,PCNA,1
R-HSA-69166,R-HSA-69166,Removal of the Flap Intermediate,1/107,14/8183,0.168411321470332,0.432766062444974,0.369591671998687,PCNA,1
R-HSA-72702,R-HSA-72702,Ribosomal scanning and start codon recognition,2/107,57/8183,0.170767424281295,0.43617703551367,0.372504717519123,EIF5/EIF4A2,2
R-HSA-5357801,R-HSA-5357801,Programmed Cell Death,4/107,166/8183,0.172130584599553,0.436924002886,0.373142643974141,SFN/PMAIP1/CYCS/DYNLL1,4
R-HSA-8943724,R-HSA-8943724,Regulation of PTEN gene transcription,2/107,58/8183,0.175440040338354,0.436924002886,0.373142643974141,EGR1/JUN,2
R-HSA-111447,R-HSA-111447,Activation of BAD and translocation to mitochondria ,1/107,15/8183,0.179303718165481,0.436924002886,0.373142643974141,SFN,1
R-HSA-197264,R-HSA-197264,Nicotinamide salvaging,1/107,15/8183,0.179303718165481,0.436924002886,0.373142643974141,NAXE,1
R-HSA-204174,R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,1/107,15/8183,0.179303718165481,0.436924002886,0.373142643974141,PDK4,1
R-HSA-5358508,R-HSA-5358508,Mismatch Repair,1/107,15/8183,0.179303718165481,0.436924002886,0.373142643974141,PCNA,1
R-HSA-69183,R-HSA-69183,Processive synthesis on the lagging strand,1/107,15/8183,0.179303718165481,0.436924002886,0.373142643974141,PCNA,1
R-HSA-9614657,R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/107,15/8183,0.179303718165481,0.436924002886,0.373142643974141,CITED2,1
R-HSA-948021,R-HSA-948021,Transport to the Golgi and subsequent modification,4/107,170/8183,0.18248369557067,0.442131925268367,0.37759032346653,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-6796648,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,2/107,61/8183,0.189575835003313,0.448365370167095,0.382913821592554,FOS/JUN,2
R-HSA-110312,R-HSA-110312,Translesion synthesis by REV1,1/107,16/8183,0.190054759075899,0.448365370167095,0.382913821592554,PCNA,1
R-HSA-1433559,R-HSA-1433559,Regulation of KIT signaling,1/107,16/8183,0.190054759075899,0.448365370167095,0.382913821592554,SOCS1,1
R-HSA-399954,R-HSA-399954,Sema3A PAK dependent Axon repulsion,1/107,16/8183,0.190054759075899,0.448365370167095,0.382913821592554,CFL1,1
R-HSA-166016,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,3/107,115/8183,0.19034378922188,0.448365370167095,0.382913821592554,FOS/SOCS1/JUN,3
R-HSA-373080,R-HSA-373080,Class B/2 (Secretin family receptors),2/107,63/8183,0.199085176963205,0.45017193069304,0.384456663749766,CALCB/ADM,2
R-HSA-373755,R-HSA-373755,Semaphorin interactions,2/107,63/8183,0.199085176963205,0.45017193069304,0.384456663749766,RHOB/CFL1,2
R-HSA-450294,R-HSA-450294,MAP kinase activation,2/107,63/8183,0.199085176963205,0.45017193069304,0.384456663749766,FOS/JUN,2
R-HSA-163560,R-HSA-163560,Triglyceride catabolism,1/107,17/8183,0.200666261558926,0.45017193069304,0.384456663749766,FABP5,1
R-HSA-450513,R-HSA-450513,Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA,1/107,17/8183,0.200666261558926,0.45017193069304,0.384456663749766,ZFP36,1
R-HSA-5621480,R-HSA-5621480,Dectin-2 family,1/107,17/8183,0.200666261558926,0.45017193069304,0.384456663749766,MUC12,1
R-HSA-5655862,R-HSA-5655862,Translesion synthesis by POLK,1/107,17/8183,0.200666261558926,0.45017193069304,0.384456663749766,PCNA,1
R-HSA-5656121,R-HSA-5656121,Translesion synthesis by POLI,1/107,17/8183,0.200666261558926,0.45017193069304,0.384456663749766,PCNA,1
R-HSA-977068,R-HSA-977068,Termination of O-glycan biosynthesis,1/107,17/8183,0.200666261558926,0.45017193069304,0.384456663749766,MUC12,1
R-HSA-422475,R-HSA-422475,Axon guidance,9/107,498/8183,0.202916712336266,0.452824663318825,0.386722155366623,RHOB/TUBB2A/TUBA1B/CFL1/TUBA1A/RPL24/RPL14/RPL35A/RPL11,9
R-HSA-6803204,R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,1/107,18/8183,0.211140019826523,0.462691313224005,0.395148489943043,PMAIP1,1
R-HSA-2467813,R-HSA-2467813,Separation of Sister Chromatids,4/107,181/8183,0.211962161425536,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-1474290,R-HSA-1474290,Collagen formation,2/107,67/8183,0.218265519270818,0.462691313224005,0.395148489943043,P4HA1/PPIB,2
R-HSA-9009391,R-HSA-9009391,Non-genomic estrogen signaling,2/107,67/8183,0.218265519270818,0.462691313224005,0.395148489943043,FOS/HSPB1,2
R-HSA-1362277,R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/107,19/8183,0.221477805237247,0.462691313224005,0.395148489943043,PCNA,1
R-HSA-5218921,R-HSA-5218921,VEGFR2 mediated cell proliferation,1/107,19/8183,0.221477805237247,0.462691313224005,0.395148489943043,VEGFA,1
R-HSA-5668599,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,1/107,19/8183,0.221477805237247,0.462691313224005,0.395148489943043,CYBA,1
R-HSA-982772,R-HSA-982772,Growth hormone receptor signaling,1/107,19/8183,0.221477805237247,0.462691313224005,0.395148489943043,SOCS1,1
R-HSA-448424,R-HSA-448424,Interleukin-17 signaling,2/107,68/8183,0.223087644831609,0.462691313224005,0.395148489943043,FOS/JUN,2
R-HSA-983231,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,3/107,126/8183,0.227636463917053,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-380259,R-HSA-380259,Loss of Nlp from mitotic centrosomes,2/107,69/8183,0.227918417678008,0.462691313224005,0.395148489943043,TUBA1A/DYNLL1,2
R-HSA-380284,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,2/107,69/8183,0.227918417678008,0.462691313224005,0.395148489943043,TUBA1A/DYNLL1,2
R-HSA-6811442,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,4/107,187/8183,0.228585438627369,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-69275,R-HSA-69275,G2/M Transition,4/107,187/8183,0.228585438627369,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-9018519,R-HSA-9018519,Estrogen-dependent gene expression,3/107,127/8183,0.231097583079216,0.462691313224005,0.395148489943043,FOS/FOSB/JUN,3
R-HSA-420029,R-HSA-420029,Tight junction interactions,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,CLDN4,1
R-HSA-5625900,R-HSA-5625900,RHO GTPases activate CIT,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,RHOB,1
R-HSA-6803157,R-HSA-6803157,Antimicrobial peptides,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,CHGA,1
R-HSA-6804115,R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,BTG2,1
R-HSA-69186,R-HSA-69186,Lagging Strand Synthesis,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,PCNA,1
R-HSA-8862803,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,JUN,1
R-HSA-8863678,R-HSA-8863678,Neurodegenerative Diseases,1/107,20/8183,0.231681366584578,0.462691313224005,0.395148489943043,JUN,1
R-HSA-453274,R-HSA-453274,Mitotic G2-G2/M phases,4/107,189/8183,0.234200701958876,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-5617833,R-HSA-5617833,Cilium Assembly,4/107,190/8183,0.237021251471187,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-8939211,R-HSA-8939211,ESR-mediated signaling,4/107,190/8183,0.237021251471187,0.462691313224005,0.395148489943043,FOS/FOSB/HSPB1/JUN,4
R-HSA-1234174,R-HSA-1234174,Cellular response to hypoxia,2/107,71/8183,0.237601774825673,0.462691313224005,0.395148489943043,CITED2/VEGFA,2
R-HSA-416572,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,1/107,21/8183,0.241752430381644,0.462691313224005,0.395148489943043,RHOB,1
R-HSA-5651801,R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,1/107,21/8183,0.241752430381644,0.462691313224005,0.395148489943043,PCNA,1
R-HSA-8956321,R-HSA-8956321,Nucleotide salvage,1/107,21/8183,0.241752430381644,0.462691313224005,0.395148489943043,APRT,1
R-HSA-9634638,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/107,21/8183,0.241752430381644,0.462691313224005,0.395148489943043,FOS,1
R-HSA-8854518,R-HSA-8854518,AURKA Activation by TPX2,2/107,72/8183,0.242452356456955,0.462691313224005,0.395148489943043,TUBA1A/DYNLL1,2
R-HSA-68882,R-HSA-68882,Mitotic Anaphase,4/107,192/8183,0.242687092063148,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-416476,R-HSA-416476,G alpha (q) signalling events,3/107,131/8183,0.245037768745116,0.462691313224005,0.395148489943043,RGS2/RGS16/GRP,3
R-HSA-2555396,R-HSA-2555396,Mitotic Metaphase and Anaphase,4/107,193/8183,0.245531946875946,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-68877,R-HSA-68877,Mitotic Prometaphase,4/107,193/8183,0.245531946875946,0.462691313224005,0.395148489943043,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-8852135,R-HSA-8852135,Protein ubiquitination,2/107,73/8183,0.247307579099973,0.463975281143312,0.396245026597069,PCNA/UBE2S,2
R-HSA-77387,R-HSA-77387,Insulin receptor recycling,1/107,22/8183,0.251692701142385,0.468941213990843,0.400486041739945,ATP6V0B,1
R-HSA-1912408,R-HSA-1912408,Pre-NOTCH Transcription and Translation,2/107,74/8183,0.252166501863,0.468941213990843,0.400486041739945,JUN/ELF3,2
R-HSA-5358351,R-HSA-5358351,Signaling by Hedgehog,3/107,134/8183,0.25558205294848,0.473217425546531,0.404138019831198,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-5625740,R-HSA-5625740,RHO GTPases activate PKNs,2/107,75/8183,0.257028207218035,0.473825912436725,0.40465768092908,RHOB/SFN,2
R-HSA-1266695,R-HSA-1266695,Interleukin-7 signaling,1/107,24/8183,0.271187573277153,0.489291621572396,0.417865734411381,SOCS1,1
R-HSA-174417,R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,1/107,24/8183,0.271187573277153,0.489291621572396,0.417865734411381,PCNA,1
R-HSA-379716,R-HSA-379716,Cytosolic tRNA aminoacylation,1/107,24/8183,0.271187573277153,0.489291621572396,0.417865734411381,DARS,1
R-HSA-400685,R-HSA-400685,Sema4D in semaphorin signaling,1/107,24/8183,0.271187573277153,0.489291621572396,0.417865734411381,RHOB,1
R-HSA-4090294,R-HSA-4090294,SUMOylation of intracellular receptors,1/107,24/8183,0.271187573277153,0.489291621572396,0.417865734411381,NR4A2,1
R-HSA-376176,R-HSA-376176,Signaling by ROBO receptors,4/107,205/8183,0.280206658409542,0.493302156438346,0.421290818805341,RPL24/RPL14/RPL35A/RPL11,4
R-HSA-196807,R-HSA-196807,Nicotinate metabolism,1/107,25/8183,0.280745476164682,0.493302156438346,0.421290818805341,NAXE,1
R-HSA-429947,R-HSA-429947,Deadenylation of mRNA,1/107,25/8183,0.280745476164682,0.493302156438346,0.421290818805341,EIF4A2,1
R-HSA-5674400,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/107,25/8183,0.280745476164682,0.493302156438346,0.421290818805341,NR4A1,1
R-HSA-5696397,R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,1/107,25/8183,0.280745476164682,0.493302156438346,0.421290818805341,PCNA,1
R-HSA-983170,R-HSA-983170,Antigen Presentation: Folding, assembly and peptide loading of class I MHC,1/107,25/8183,0.280745476164682,0.493302156438346,0.421290818805341,HSPA5,1
R-HSA-168142,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/107,81/8183,0.286208326612814,0.493302156438346,0.421290818805341,FOS/JUN,2
R-HSA-168176,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/107,81/8183,0.286208326612814,0.493302156438346,0.421290818805341,FOS/JUN,2
R-HSA-380270,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,2/107,81/8183,0.286208326612814,0.493302156438346,0.421290818805341,TUBA1A/DYNLL1,2
R-HSA-380287,R-HSA-380287,Centrosome maturation,2/107,81/8183,0.286208326612814,0.493302156438346,0.421290818805341,TUBA1A/DYNLL1,2
R-HSA-975871,R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/107,81/8183,0.286208326612814,0.493302156438346,0.421290818805341,FOS/JUN,2
R-HSA-112315,R-HSA-112315,Transmission across Chemical Synapses,4/107,208/8183,0.289004586779456,0.494120387077698,0.42198960564729,TUBB2A/TUBA1B/TUBA1A/GLUL,4
R-HSA-110373,R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,1/107,26/8183,0.290179189581007,0.494120387077698,0.42198960564729,PCNA,1
R-HSA-1483191,R-HSA-1483191,Synthesis of PC,1/107,26/8183,0.290179189581007,0.494120387077698,0.42198960564729,MFSD2A,1
R-HSA-983169,R-HSA-983169,Class I MHC mediated antigen processing & presentation,6/107,344/8183,0.294229726620114,0.499013616347713,0.426168530346607,MYLIP/SOCS1/UBE2S/CYBA/HSPA5/WSB1,6
R-HSA-1852241,R-HSA-1852241,Organelle biogenesis and maintenance,5/107,277/8183,0.295966637108416,0.499936584044955,0.426956764924192,TUBB2A/TUBA1B/TUBA1A/CYCS/DYNLL1,5
R-HSA-1538133,R-HSA-1538133,G0 and Early G1,1/107,27/8183,0.299490312140138,0.499936584044955,0.426956764924192,PCNA,1
R-HSA-156590,R-HSA-156590,Glutathione conjugation,1/107,27/8183,0.299490312140138,0.499936584044955,0.426956764924192,GGCT,1
R-HSA-8979227,R-HSA-8979227,Triglyceride metabolism,1/107,27/8183,0.299490312140138,0.499936584044955,0.426956764924192,FABP5,1
R-HSA-975138,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/107,84/8183,0.300768390711902,0.500101167301359,0.427097322620823,FOS/JUN,2
R-HSA-168181,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/107,85/8183,0.305612292407032,0.503386534455225,0.429903097945872,FOS/JUN,2
R-HSA-975155,R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/107,85/8183,0.305612292407032,0.503386534455225,0.429903097945872,FOS/JUN,2
R-HSA-114604,R-HSA-114604,GPVI-mediated activation cascade,1/107,28/8183,0.3086804220716,0.503386534455225,0.429903097945872,RHOB,1
R-HSA-69205,R-HSA-69205,G1/S-Specific Transcription,1/107,28/8183,0.3086804220716,0.503386534455225,0.429903097945872,PCNA,1
R-HSA-917977,R-HSA-917977,Transferrin endocytosis and recycling,1/107,28/8183,0.3086804220716,0.503386534455225,0.429903097945872,ATP6V0B,1
R-HSA-2565942,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,2/107,86/8183,0.310450305072093,0.504333062645852,0.430711453699536,TUBA1A/DYNLL1,2
R-HSA-2129379,R-HSA-2129379,Molecules associated with elastic fibres,1/107,29/8183,0.317751077477896,0.509785017033982,0.435367541856231,ELN,1
R-HSA-70614,R-HSA-70614,Amino acid synthesis and interconversion (transamination),1/107,29/8183,0.317751077477896,0.509785017033982,0.435367541856231,GLUL,1
R-HSA-8964043,R-HSA-8964043,Plasma lipoprotein clearance,1/107,29/8183,0.317751077477896,0.509785017033982,0.435367541856231,MYLIP,1
R-HSA-168138,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/107,89/8183,0.324922404580895,0.509785017033982,0.435367541856231,FOS/JUN,2
R-HSA-2559582,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),2/107,89/8183,0.324922404580895,0.509785017033982,0.435367541856231,FOS/JUN,2
R-HSA-110314,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,1/107,30/8183,0.326703816588745,0.509785017033982,0.435367541856231,PCNA,1
R-HSA-180786,R-HSA-180786,Extension of Telomeres,1/107,30/8183,0.326703816588745,0.509785017033982,0.435367541856231,PCNA,1
R-HSA-2173782,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,1/107,30/8183,0.326703816588745,0.509785017033982,0.435367541856231,HSPH1,1
R-HSA-499943,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,1/107,30/8183,0.326703816588745,0.509785017033982,0.435367541856231,CTPS1,1
R-HSA-8866652,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/107,30/8183,0.326703816588745,0.509785017033982,0.435367541856231,UBE2S,1
R-HSA-15869,R-HSA-15869,Metabolism of nucleotides,2/107,90/8183,0.329730346318902,0.509785017033982,0.435367541856231,CTPS1/APRT,2
R-HSA-168164,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/107,90/8183,0.329730346318902,0.509785017033982,0.435367541856231,FOS/JUN,2
R-HSA-1912422,R-HSA-1912422,Pre-NOTCH Expression and Processing,2/107,90/8183,0.329730346318902,0.509785017033982,0.435367541856231,JUN/ELF3,2
R-HSA-112314,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,3/107,155/8183,0.330638867180059,0.509785017033982,0.435367541856231,TUBB2A/TUBA1B/TUBA1A,3
R-HSA-2173796,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/107,31/8183,0.335540158012148,0.514195328196272,0.439134043941206,JUNB,1
R-HSA-5663205,R-HSA-5663205,Infectious disease,6/107,362/8183,0.335924778090489,0.514195328196272,0.439134043941206,HSPA1B/HSPA1A/RPL24/RPL14/RPL35A/RPL11,6
R-HSA-375276,R-HSA-375276,Peptide ligand-binding receptors,2/107,93/8183,0.344097510897276,0.519387747019319,0.443568483055228,NPW/GRP,2
R-HSA-5656169,R-HSA-5656169,Termination of translesion DNA synthesis,1/107,32/8183,0.344261600982302,0.519387747019319,0.443568483055228,PCNA,1
R-HSA-69190,R-HSA-69190,DNA strand elongation,1/107,32/8183,0.344261600982302,0.519387747019319,0.443568483055228,PCNA,1
R-HSA-8950505,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,1/107,32/8183,0.344261600982302,0.519387747019319,0.443568483055228,CFL1,1
R-HSA-500792,R-HSA-500792,GPCR ligand binding,4/107,227/8183,0.345441850611906,0.519387747019319,0.443568483055228,CALCB/ADM/NPW/GRP,4
R-HSA-166166,R-HSA-166166,MyD88-independent TLR4 cascade ,2/107,94/8183,0.348865793291298,0.52084188857574,0.444810351713145,FOS/JUN,2
R-HSA-937061,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/107,94/8183,0.348865793291298,0.52084188857574,0.444810351713145,FOS/JUN,2
R-HSA-2559585,R-HSA-2559585,Oncogene Induced Senescence,1/107,33/8183,0.352869625604421,0.523135389007954,0.44676905118852,ID1,1
R-HSA-75105,R-HSA-75105,Fatty acyl-CoA biosynthesis,1/107,33/8183,0.352869625604421,0.523135389007954,0.44676905118852,PPT1,1
R-HSA-913531,R-HSA-913531,Interferon Signaling,3/107,162/8183,0.355791881279959,0.52395869239749,0.447472170269952,EGR1/SOCS1/EIF4A2,3
R-HSA-5617472,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,2/107,96/8183,0.358367973573755,0.52395869239749,0.447472170269952,HOXD1/JUN,2
R-HSA-5619507,R-HSA-5619507,Activation of HOX genes during differentiation,2/107,96/8183,0.358367973573755,0.52395869239749,0.447472170269952,HOXD1/JUN,2
R-HSA-5620912,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,2/107,96/8183,0.358367973573755,0.52395869239749,0.447472170269952,TUBA1A/DYNLL1,2
R-HSA-1257604,R-HSA-1257604,PIP3 activates AKT signaling,4/107,233/8183,0.363386646227407,0.529470577321033,0.452179440413196,EGR1/NR4A1/IER3/JUN,4
R-HSA-1566948,R-HSA-1566948,Elastic fibre formation,1/107,35/8183,0.369751246027972,0.536899069574863,0.458523535088761,ELN,1
R-HSA-2559583,R-HSA-2559583,Cellular Senescence,3/107,168/8183,0.377267903253965,0.543334740432436,0.464019738601684,FOS/ID1/JUN,3
R-HSA-6804757,R-HSA-6804757,Regulation of TP53 Degradation,1/107,36/8183,0.378027708555587,0.543334740432436,0.464019738601684,SGK1,1
R-HSA-6806003,R-HSA-6806003,Regulation of TP53 Expression and Degradation,1/107,36/8183,0.378027708555587,0.543334740432436,0.464019738601684,SGK1,1
R-HSA-3769402,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,1/107,37/8183,0.38619648665606,0.553200372777599,0.472445204159618,SOX4,1
R-HSA-418597,R-HSA-418597,G alpha (z) signalling events,1/107,38/8183,0.394258968356011,0.560959069070297,0.479071300298367,RGS16,1
R-HSA-9020591,R-HSA-9020591,Interleukin-12 signaling,1/107,38/8183,0.394258968356011,0.560959069070297,0.479071300298367,CFL1,1
R-HSA-2559580,R-HSA-2559580,Oxidative Stress Induced Senescence,2/107,104/8183,0.39584713134167,0.561335062504575,0.479392406905595,FOS/JUN,2
R-HSA-388396,R-HSA-388396,GPCR downstream signalling,7/107,461/8183,0.398246501813292,0.562855055896119,0.480690514469377,RHOB/RGS2/RGS16/CALCB/ADM/NPW/GRP,7
R-HSA-73933,R-HSA-73933,Resolution of Abasic Sites (AP sites),1/107,39/8183,0.402216523958946,0.566577429098316,0.483869502507003,PCNA,1
R-HSA-1433557,R-HSA-1433557,Signaling by SCF-KIT,1/107,41/8183,0.417822250814313,0.582752086662068,0.497683013435332,SOCS1,1
R-HSA-3928662,R-HSA-3928662,EPHB-mediated forward signaling,1/107,41/8183,0.417822250814313,0.582752086662068,0.497683013435332,CFL1,1
R-HSA-5696400,R-HSA-5696400,Dual Incision in GG-NER,1/107,41/8183,0.417822250814313,0.582752086662068,0.497683013435332,PCNA,1
R-HSA-71387,R-HSA-71387,Metabolism of carbohydrates,4/107,253/8183,0.422940513287767,0.585716182630163,0.500214416148898,ALDOA/GPI/ENO1/PGK1,4
R-HSA-2426168,R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/107,42/8183,0.425473076061534,0.585716182630163,0.500214416148898,FDFT1,1
R-HSA-379724,R-HSA-379724,tRNA Aminoacylation,1/107,42/8183,0.425473076061534,0.585716182630163,0.500214416148898,DARS,1
R-HSA-8854214,R-HSA-8854214,TBC/RABGAPs,1/107,42/8183,0.425473076061534,0.585716182630163,0.500214416148898,MAP1LC3B,1
R-HSA-418555,R-HSA-418555,G alpha (s) signalling events,2/107,112/8183,0.432318041772832,0.59226547181143,0.505807652192483,CALCB/ADM,2
R-HSA-2173793,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/107,43/8183,0.433024283635716,0.59226547181143,0.505807652192483,JUNB,1
R-HSA-4615885,R-HSA-4615885,SUMOylation of DNA replication proteins,1/107,44/8183,0.440477158531413,0.600521913882055,0.512858834099868,PCNA,1
R-HSA-447115,R-HSA-447115,Interleukin-12 family signaling,1/107,45/8183,0.447832969323542,0.608593522414045,0.519752164127188,CFL1,1
R-HSA-421270,R-HSA-421270,Cell-cell junction organization,1/107,47/8183,0.462258392042872,0.626190281872772,0.534780181142586,CLDN4,1
R-HSA-913709,R-HSA-913709,O-linked glycosylation of mucins,1/107,48/8183,0.469330460879083,0.633745590486405,0.541232579759988,MUC12,1
R-HSA-9006925,R-HSA-9006925,Intracellular signaling by second messengers,4/107,271/8183,0.475430887065893,0.635080506443315,0.542372627151192,EGR1/NR4A1/IER3/JUN,4
R-HSA-8957322,R-HSA-8957322,Metabolism of steroids,2/107,122/8183,0.476229033949715,0.635080506443315,0.542372627151192,MSMO1/FDFT1,2
R-HSA-174824,R-HSA-174824,Plasma lipoprotein assembly, remodeling, and clearance,1/107,49/8183,0.476310379832486,0.635080506443315,0.542372627151192,MYLIP,1
R-HSA-381070,R-HSA-381070,IRE1alpha activates chaperones,1/107,49/8183,0.476310379832486,0.635080506443315,0.542372627151192,HSPA5,1
R-HSA-2454202,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/107,124/8183,0.484766974553225,0.644329771819961,0.550271701852201,FOS/JUN,2
R-HSA-917937,R-HSA-917937,Iron uptake and transport,1/107,51/8183,0.489998511049214,0.649248027140208,0.554471999345163,ATP6V0B,1
R-HSA-3906995,R-HSA-3906995,Diseases associated with O-glycosylation of proteins,1/107,52/8183,0.496709056956461,0.654051677483042,0.558574421683631,MUC12,1
R-HSA-72165,R-HSA-72165,mRNA Splicing - Minor Pathway,1/107,52/8183,0.496709056956461,0.654051677483042,0.558574421683631,SRSF7,1
R-HSA-8866654,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,1/107,53/8183,0.503332120651659,0.660720802341497,0.564270000013593,PCNA,1
R-HSA-446203,R-HSA-446203,Asparagine N-linked glycosylation,4/107,283/8183,0.509451652064613,0.665182722335519,0.568080577168368,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-2151201,R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,1/107,54/8183,0.509868831978876,0.665182722335519,0.568080577168368,CYCS,1
R-HSA-1655829,R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/107,55/8183,0.516320306327291,0.671533159149605,0.573503988946038,FDFT1,1
R-HSA-429914,R-HSA-429914,Deadenylation-dependent mRNA decay,1/107,56/8183,0.52268764481437,0.673525826468169,0.575205770370036,EIF4A2,1
R-HSA-6807070,R-HSA-6807070,PTEN Regulation,2/107,134/8183,0.526152661375795,0.673525826468169,0.575205770370036,EGR1/JUN,2
R-HSA-983168,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,4/107,290/8183,0.528849788288078,0.673525826468169,0.575205770370036,MYLIP/SOCS1/UBE2S/WSB1,4
R-HSA-2029482,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/107,57/8183,0.528971934466746,0.673525826468169,0.575205770370036,CFL1,1
R-HSA-72187,R-HSA-72187,mRNA 3'-end processing,1/107,57/8183,0.528971934466746,0.673525826468169,0.575205770370036,SRSF7,1
R-HSA-72649,R-HSA-72649,Translation initiation complex formation,1/107,57/8183,0.528971934466746,0.673525826468169,0.575205770370036,EIF4A2,1
R-HSA-8986944,R-HSA-8986944,Transcriptional Regulation by MECP2,1/107,57/8183,0.528971934466746,0.673525826468169,0.575205770370036,SGK1,1
R-HSA-72662,R-HSA-72662,Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S,1/107,58/8183,0.535174248398823,0.679382878206889,0.580207820514325,EIF4A2,1
R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,3/107,216/8183,0.540213136373624,0.683732447231094,0.583922447486336,P4HA1/ELN/PPIB,3
R-HSA-163125,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,1/107,60/8183,0.547337173054522,0.688637867581951,0.588111783635032,NRN1,1
R-HSA-6790901,R-HSA-6790901,rRNA modification in the nucleus and cytosol,1/107,60/8183,0.547337173054522,0.688637867581951,0.588111783635032,BUD23,1
R-HSA-1268020,R-HSA-1268020,Mitochondrial protein import,1/107,61/8183,0.553299862022042,0.694080300288006,0.592759740067215,TOMM20,1
R-HSA-1221632,R-HSA-1221632,Meiotic synapsis,1/107,62/8183,0.559184732098827,0.697336254146772,0.595540395795654,HSPA2,1
R-HSA-74752,R-HSA-74752,Signaling by Insulin receptor,1/107,62/8183,0.559184732098827,0.697336254146772,0.595540395795654,ATP6V0B,1
R-HSA-373076,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),2/107,145/8183,0.569056435328829,0.707565530937593,0.604276421654747,NPW/GRP,2
R-HSA-6782210,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,1/107,64/8183,0.57072502731287,0.707565530937593,0.604276421654747,PCNA,1
R-HSA-983712,R-HSA-983712,Ion channel transport,2/107,146/8183,0.572816910794928,0.708088542790231,0.604723085203177,SGK1/ATP6V0B,2
R-HSA-6782135,R-HSA-6782135,Dual incision in TC-NER,1/107,65/8183,0.576382426263175,0.710424850975541,0.606718343434921,PCNA,1
R-HSA-73856,R-HSA-73856,RNA Polymerase II Transcription Termination,1/107,66/8183,0.581965954273749,0.715227723513245,0.610820101510815,SRSF7,1
R-HSA-156580,R-HSA-156580,Phase II - Conjugation of compounds,1/107,67/8183,0.587476566925308,0.715776047058422,0.611288381797659,GGCT,1
R-HSA-416482,R-HSA-416482,G alpha (12/13) signalling events,1/107,67/8183,0.587476566925308,0.715776047058422,0.611288381797659,RHOB,1
R-HSA-5685942,R-HSA-5685942,HDR through Homologous Recombination (HRR),1/107,67/8183,0.587476566925308,0.715776047058422,0.611288381797659,PCNA,1
R-HSA-112316,R-HSA-112316,Neuronal System,4/107,314/8183,0.592407970302341,0.7182744228649,0.613422049318583,TUBB2A/TUBA1B/TUBA1A/GLUL,4
R-HSA-157579,R-HSA-157579,Telomere Maintenance,1/107,68/8183,0.592915207553573,0.7182744228649,0.613422049318583,PCNA,1
R-HSA-1169408,R-HSA-1169408,ISG15 antiviral mechanism,1/107,70/8183,0.603580285788674,0.729111228417088,0.622676918012608,EIF4A2,1
R-HSA-9006934,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,5/107,400/8183,0.605444508682644,0.729194421745608,0.622747966932694,SOCS1/HSPB1/ATP6V0B/CYBA/VEGFA,5
R-HSA-159236,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,1/107,71/8183,0.608808550231003,0.729194421745608,0.622747966932694,SRSF7,1
R-HSA-877300,R-HSA-877300,Interferon gamma signaling,1/107,71/8183,0.608808550231003,0.729194421745608,0.622747966932694,SOCS1,1
R-HSA-446728,R-HSA-446728,Cell junction organization,1/107,73/8183,0.619061009365551,0.739385543580263,0.631451407625647,CLDN4,1
R-HSA-1169410,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,1/107,77/8183,0.638774017994324,0.759274011593146,0.648436593813412,EIF4A2,1
R-HSA-6781827,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),1/107,78/8183,0.643542236607031,0.759274011593146,0.648436593813412,PCNA,1
R-HSA-6811558,R-HSA-6811558,PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling,1/107,78/8183,0.643542236607031,0.759274011593146,0.648436593813412,IER3,1
R-HSA-73884,R-HSA-73884,Base Excision Repair,1/107,78/8183,0.643542236607031,0.759274011593146,0.648436593813412,PCNA,1
R-HSA-3108232,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,2/107,167/8183,0.646332157449373,0.759274011593146,0.648436593813412,NR4A2/PCNA,2
R-HSA-2029480,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/107,79/8183,0.648248094803582,0.759274011593146,0.648436593813412,CFL1,1
R-HSA-351202,R-HSA-351202,Metabolism of polyamines,1/107,79/8183,0.648248094803582,0.759274011593146,0.648436593813412,SAT1,1
R-HSA-72202,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,1/107,80/8183,0.652892400560741,0.761026051361701,0.649932874052694,SRSF7,1
R-HSA-5688426,R-HSA-5688426,Deubiquitination,3/107,255/8183,0.653333685602969,0.761026051361701,0.649932874052694,UCHL1/UFD1/TOMM20,3
R-HSA-2219528,R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/107,81/8183,0.65747595148509,0.763752886108708,0.652261650499989,NR4A1,1
R-HSA-2672351,R-HSA-2672351,Stimuli-sensing channels,1/107,82/8183,0.661999534944865,0.76690656507274,0.654954961233919,SGK1,1
R-HSA-2990846,R-HSA-2990846,SUMOylation,2/107,173/8183,0.665433944571994,0.768784720704429,0.65655894717558,NR4A2/PCNA,2
R-HSA-5696399,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),1/107,84/8183,0.670869898531313,0.771677946704144,0.659029825387849,PCNA,1
R-HSA-199418,R-HSA-199418,Negative regulation of the PI3K/AKT network,1/107,85/8183,0.675218203366126,0.771677946704144,0.659029825387849,IER3,1
R-HSA-5173105,R-HSA-5173105,O-linked glycosylation,1/107,85/8183,0.675218203366126,0.771677946704144,0.659029825387849,MUC12,1
R-HSA-69473,R-HSA-69473,G2/M DNA damage checkpoint,1/107,85/8183,0.675218203366126,0.771677946704144,0.659029825387849,SFN,1
R-HSA-1592230,R-HSA-1592230,Mitochondrial biogenesis,1/107,87/8183,0.683744797744225,0.777232692341961,0.663773699517464,CYCS,1
R-HSA-2682334,R-HSA-2682334,EPH-Ephrin signaling,1/107,87/8183,0.683744797744225,0.777232692341961,0.663773699517464,CFL1,1
R-HSA-5689880,R-HSA-5689880,Ub-specific processing proteases,2/107,180/8183,0.686672377218148,0.778473497167098,0.664833373946082,UFD1/TOMM20,2
R-HSA-1236975,R-HSA-1236975,Antigen processing-Cross presentation,1/107,89/8183,0.692049578424544,0.782477390005351,0.668252785903279,CYBA,1
R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/107,91/8183,0.700138262711643,0.789517615398236,0.674265292197103,IGFBP2,1
R-HSA-68886,R-HSA-68886,M Phase,4/107,364/8183,0.707528989351634,0.792303764107042,0.676644724063611,TUBB2A/TUBA1B/TUBA1A/DYNLL1,4
R-HSA-8878159,R-HSA-8878159,Transcriptional regulation by RUNX3,1/107,93/8183,0.708016421912676,0.792303764107042,0.676644724063611,BRD2,1
R-HSA-1500620,R-HSA-1500620,Meiosis,1/107,94/8183,0.711878256629035,0.792303764107042,0.676644724063611,HSPA2,1
R-HSA-141424,R-HSA-141424,Amplification of signal from the kinetochores,1/107,95/8183,0.715689485030654,0.792303764107042,0.676644724063611,DYNLL1,1
R-HSA-141444,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,1/107,95/8183,0.715689485030654,0.792303764107042,0.676644724063611,DYNLL1,1
R-HSA-1474228,R-HSA-1474228,Degradation of the extracellular matrix,1/107,95/8183,0.715689485030654,0.792303764107042,0.676644724063611,ELN,1
R-HSA-5689603,R-HSA-5689603,UCH proteinases,1/107,95/8183,0.715689485030654,0.792303764107042,0.676644724063611,UCHL1,1
R-HSA-73886,R-HSA-73886,Chromosome Maintenance,1/107,96/8183,0.719450764098621,0.794393552025561,0.67842944860177,PCNA,1
R-HSA-1500931,R-HSA-1500931,Cell-Cell communication,1/107,102/8183,0.741005242329742,0.816068111033274,0.696939995519976,CLDN4,1
R-HSA-196849,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/107,103/8183,0.744434575218088,0.817720880550438,0.698351496795806,NAXE,1
R-HSA-1483206,R-HSA-1483206,Glycerophospholipid biosynthesis,1/107,104/8183,0.747818919333393,0.818743846727111,0.699225132259499,MFSD2A,1
R-HSA-1474165,R-HSA-1474165,Reproduction,1/107,105/8183,0.751158859379355,0.818743846727111,0.699225132259499,HSPA2,1
R-HSA-1989781,R-HSA-1989781,PPARA activates gene expression,1/107,105/8183,0.751158859379355,0.818743846727111,0.699225132259499,FDFT1,1
R-HSA-400206,R-HSA-400206,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),1/107,107/8183,0.757707828535271,0.823764408458859,0.703512801662978,FDFT1,1
R-HSA-5673001,R-HSA-5673001,RAF/MAP kinase cascade,2/107,208/8183,0.760872808506573,0.825089695158023,0.704644625457696,DUSP2/DUSP1,2
R-HSA-5696398,R-HSA-5696398,Nucleotide Excision Repair,1/107,110/8183,0.767212441597687,0.82894993946145,0.707941358427852,PCNA,1
R-HSA-157118,R-HSA-157118,Signaling by NOTCH,2/107,212/8183,0.770147136951318,0.82894993946145,0.707941358427852,JUN/ELF3,2
R-HSA-69618,R-HSA-69618,Mitotic Spindle Checkpoint,1/107,111/8183,0.770297821103329,0.82894993946145,0.707941358427852,DYNLL1,1
R-HSA-5684996,R-HSA-5684996,MAPK1/MAPK3 signaling,2/107,213/8183,0.7724168220897,0.829125905230463,0.708091637038926,DUSP2/DUSP1,2
R-HSA-9007101,R-HSA-9007101,Rab regulation of trafficking,1/107,116/8183,0.78512740987971,0.840641469164134,0.717926180219618,MAP1LC3B,1
R-HSA-69239,R-HSA-69239,Synthesis of DNA,1/107,117/8183,0.787977461589499,0.841567868297098,0.718717345318276,PCNA,1
R-HSA-5693567,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),1/107,122/8183,0.801675565951258,0.851065011099214,0.726828112756032,PCNA,1
R-HSA-194840,R-HSA-194840,Rho GTPase cycle,1/107,123/8183,0.804308082319353,0.851065011099214,0.726828112756032,RHOB,1
R-HSA-3781865,R-HSA-3781865,Diseases of glycosylation,1/107,124/8183,0.806905977504444,0.851065011099214,0.726828112756032,MUC12,1
R-HSA-5621481,R-HSA-5621481,C-type lectin receptors (CLRs),1/107,124/8183,0.806905977504444,0.851065011099214,0.726828112756032,MUC12,1
R-HSA-69306,R-HSA-69306,DNA Replication,1/107,124/8183,0.806905977504444,0.851065011099214,0.726828112756032,PCNA,1
R-HSA-5693538,R-HSA-5693538,Homology Directed Repair,1/107,128/8183,0.816960281060379,0.859531412331515,0.734058604374482,PCNA,1
R-HSA-69206,R-HSA-69206,G1/S Transition,1/107,130/8183,0.821791160663475,0.86247389138939,0.736571545774454,PCNA,1
R-HSA-211859,R-HSA-211859,Biological oxidations,1/107,132/8183,0.826495701541604,0.865269573959605,0.738959119766892,GGCT,1
R-HSA-418594,R-HSA-418594,G alpha (i) signalling events,2/107,248/8183,0.840486182992165,0.877749117213493,0.749616922347174,RGS16/NPW,2
R-HSA-8978868,R-HSA-8978868,Fatty acid metabolism,1/107,143/8183,0.850254514089577,0.885768830402901,0.756465932618168,PPT1,1
R-HSA-453279,R-HSA-453279,Mitotic G1-G1/S phases,1/107,148/8183,0.859959556135152,0.893683460297315,0.763225199459474,PCNA,1
R-HSA-5633007,R-HSA-5633007,Regulation of TP53 Activity,1/107,153/8183,0.869041110751802,0.897491365555177,0.766477233741263,SGK1,1
R-HSA-9609507,R-HSA-9609507,Protein localization,1/107,153/8183,0.869041110751802,0.897491365555177,0.766477233741263,TOMM20,1
R-HSA-196854,R-HSA-196854,Metabolism of vitamins and cofactors,1/107,155/8183,0.872508135153504,0.897491365555177,0.766477233741263,NAXE,1
R-HSA-5693532,R-HSA-5693532,DNA Double-Strand Break Repair,1/107,155/8183,0.872508135153504,0.897491365555177,0.766477233741263,PCNA,1
R-HSA-69481,R-HSA-69481,G2/M Checkpoints,1/107,156/8183,0.874207391448792,0.897491365555177,0.766477233741263,SFN,1
R-HSA-69242,R-HSA-69242,S Phase,1/107,159/8183,0.879171694305716,0.900407725569139,0.76896786890711,PCNA,1
R-HSA-69620,R-HSA-69620,Cell Cycle Checkpoints,2/107,280/8183,0.88612969389421,0.905346964364205,0.773186086745995,SFN/DYNLL1,2
R-HSA-1483257,R-HSA-1483257,Phospholipid metabolism,1/107,177/8183,0.905133768207231,0.922540186826601,0.787869474350424,MFSD2A,1
R-HSA-72163,R-HSA-72163,mRNA Splicing - Major Pathway,1/107,182/8183,0.911307491245875,0.926605218916668,0.791341100564384,SRSF7,1
R-HSA-72172,R-HSA-72172,mRNA Splicing,1/107,190/8183,0.920367722115792,0.933460697971164,0.797195829449058,SRSF7,1
R-HSA-201681,R-HSA-201681,TCF dependent signaling in response to WNT,1/107,193/8183,0.923523534843014,0.933460697971164,0.797195829449058,SOX4,1
R-HSA-73894,R-HSA-73894,DNA Repair,2/107,318/8183,0.924654464971436,0.933460697971164,0.797195829449058,PCNA/UFD1,2
R-HSA-8951664,R-HSA-8951664,Neddylation,1/107,220/8183,0.946889982887559,0.953637417444952,0.814427188681886,WSB1,1
R-HSA-72203,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1/107,239/8183,0.958939934213708,0.963484673238417,0.822836960263197,SRSF7,1
R-HSA-195721,R-HSA-195721,Signaling by WNT,1/107,276/8183,0.975167890825386,0.977473252269418,0.834783512365143,SOX4,1
R-HSA-5663202,R-HSA-5663202,Diseases of signal transduction,1/107,348/8183,0.990730801369805,0.990730801369805,0.846105748935484,NR4A1,1
